Practical guidance for mismatch repair-deficiency testing in endometrial cancer
<strong>Background:</strong> Mismatch repair (MMR)-deficiency analysis is increasingly recommended for all endometrial cancers, as it identifies Lynch syndrome-patients, and is emerging as a prognostic classifier to guide adjuvant treatment. The aim of this study was to define the optima...
Main Authors: | Stelloo, E, Jansen, A, Osse, E, Nout, R, Creutzberg, C, Church, D, Morreau, H, Smit, V, van Wezel, T, Bosse, T |
---|---|
Format: | Journal article |
Published: |
Oxford University Press
2016
|
Similar Items
-
Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different Aetiologies
by: Neil A. J. Ryan, et al.
Published: (2021-09-01) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
by: Klenerman, P, et al.
Published: (2015) -
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape
by: Glaire, MA, et al.
Published: (2022) -
Prognostic integrated image-based immune and molecular profiling in early-stage endometrial cancer
by: Horeweg, N, et al.
Published: (2020) -
DNA mismatch repair deficient (dMMR) endometrial cancer
by: Chia-Hao Liu, et al.
Published: (2022-09-01)